IS2339B - Kristallað tíótrópíumbrómíðmónóhýdrat, aðferð viðað framleiða það og notkun þess í framleiðslu á lyfi - Google Patents

Kristallað tíótrópíumbrómíðmónóhýdrat, aðferð viðað framleiða það og notkun þess í framleiðslu á lyfi

Info

Publication number
IS2339B
IS2339B IS6772A IS6772A IS2339B IS 2339 B IS2339 B IS 2339B IS 6772 A IS6772 A IS 6772A IS 6772 A IS6772 A IS 6772A IS 2339 B IS2339 B IS 2339B
Authority
IS
Iceland
Prior art keywords
manufacture
medicament
tiotropium bromide
bromide monohydrate
crystalline tiotropium
Prior art date
Application number
IS6772A
Other languages
English (en)
Other versions
IS6772A (is
Inventor
Banholzer Rolf
Sieger Peter
Kulinna Christian
Trunk Michael
Ludwig August Graulich Manfred
Specht Peter
Meissner Helmut
Mathes Andreas
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7659568&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS2339(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of IS6772A publication Critical patent/IS6772A/is
Publication of IS2339B publication Critical patent/IS2339B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IS6772A 2000-10-12 2003-04-09 Kristallað tíótrópíumbrómíðmónóhýdrat, aðferð viðað framleiða það og notkun þess í framleiðslu á lyfi IS2339B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10050621 2000-10-12
PCT/EP2001/011225 WO2002030928A1 (de) 2000-10-12 2001-09-28 Kristallines monohydrat, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels

Publications (2)

Publication Number Publication Date
IS6772A IS6772A (is) 2003-04-09
IS2339B true IS2339B (is) 2008-02-15

Family

ID=7659568

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6772A IS2339B (is) 2000-10-12 2003-04-09 Kristallað tíótrópíumbrómíðmónóhýdrat, aðferð viðað framleiða það og notkun þess í framleiðslu á lyfi

Country Status (46)

Country Link
EP (2) EP1326862B1 (is)
JP (1) JP3764422B2 (is)
KR (1) KR100823860B1 (is)
CN (2) CN100519558C (is)
AP (1) AP1572A (is)
AR (2) AR034389A1 (is)
AT (1) ATE276253T1 (is)
AU (2) AU2002214996B2 (is)
BG (1) BG66161B1 (is)
BR (1) BR0114584A (is)
CA (1) CA2425539C (is)
CR (1) CR6938A (is)
CZ (1) CZ301841B6 (is)
DE (1) DE50103666D1 (is)
DK (1) DK1326862T3 (is)
DZ (1) DZ3478A1 (is)
EA (1) EA004381B1 (is)
EC (1) ECSP034540A (is)
EE (1) EE04567B1 (is)
EG (1) EG24142A (is)
ES (1) ES2228965T3 (is)
GE (1) GEP20063905B (is)
HR (1) HRP20030276B1 (is)
HU (1) HU226830B1 (is)
IL (2) IL155335A0 (is)
IS (1) IS2339B (is)
MA (1) MA25842A1 (is)
ME (2) ME00243B (is)
MX (1) MXPA03003221A (is)
MY (1) MY126931A (is)
NO (1) NO328465B1 (is)
NZ (1) NZ525733A (is)
OA (1) OA12403A (is)
PE (1) PE20020422A1 (is)
PL (1) PL207870B1 (is)
PT (1) PT1326862E (is)
RS (1) RS50218B (is)
SA (1) SA01220412B1 (is)
SI (1) SI1326862T1 (is)
SK (1) SK287009B6 (is)
TR (1) TR200402579T4 (is)
TW (1) TW589313B (is)
UA (1) UA74215C2 (is)
UY (2) UY26962A1 (is)
WO (1) WO2002030928A1 (is)
ZA (1) ZA200302500B (is)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0400333A3 (en) * 2001-06-22 2012-10-29 Boehringer Ingelheim Pharma Crystalline anticholinergic, method for its production, and use thereof in the production of pharmaceutical composition
US6608055B2 (en) 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
DE10212264A1 (de) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
US7311894B2 (en) 2002-03-28 2007-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations containing an anticholinergic
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE10317461A1 (de) 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
UY28590A1 (es) * 2003-11-03 2005-06-30 Boehringer Ingelheim Int Procedimiento para la preparación de nuevas sales de tiotropio, nuevas sales de tiotropio como tales, así como las formulaciones medicamentosas que las contienen.
SG149876A1 (en) * 2003-11-03 2009-02-27 Boehringer Ingelheim Int Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
US7968717B2 (en) 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
KR101285571B1 (ko) * 2003-11-03 2013-07-15 베링거 인겔하임 인터내셔날 게엠베하 항콜린성 효과를 지닌 신규한 무수 결정
DE102004016179A1 (de) * 2004-03-30 2005-10-20 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von proliferativen Prozessen
PT1781298E (pt) 2004-04-22 2012-02-03 Boehringer Ingelheim Int Combinações farmacêuticas contendo benzoxazinas para o tratamento de doenças respiratórias
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004024454A1 (de) 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE602004020337D1 (de) 2004-08-11 2009-05-14 Boehringer Ingelheim Pharma Anticholinergika enthaltende Arzneimittel zur Behandlung von Krankheiten der ableitenden Harnwege
US20060079544A1 (en) * 2004-08-13 2006-04-13 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
WO2006045715A1 (de) * 2004-10-21 2006-05-04 Boehringer Ingelheim International Gmbh Blister für inhalatoren
WO2006094924A2 (en) * 2005-03-09 2006-09-14 Boehringer Ingelheim International Gmbh New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
CN101163706A (zh) 2005-04-21 2008-04-16 贝林格尔·英格海姆国际有限公司 用于治疗炎性疾病的二氢噻吩并嘧啶
KR20080007645A (ko) 2005-04-28 2008-01-22 베링거 인겔하임 인터내셔날 게엠베하 염증성 질환 치료용 신규 화합물
DK1881980T3 (da) 2005-05-02 2012-10-01 Boehringer Ingelheim Int Nye krystalline former af tiotropiumbromid
AU2006243239A1 (en) * 2005-05-02 2006-11-09 Boehringer Ingelheim International Gmbh Crystalline forms of tiotropium bromide
AU2006259202B2 (en) * 2005-06-15 2012-05-10 Boehringer Ingelheim International Gmbh Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof
DE102005030733A1 (de) 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
CA2617717C (en) * 2005-08-06 2014-02-11 Boehringer Ingelheim International Gmbh Use of tiotropium salts in the treatment of severe persistant asthma
WO2007020227A1 (de) 2005-08-15 2007-02-22 Boehringer Ingelheim International Gmbh Verfahren zur herstellung von betamimetika
TWI396541B (zh) 2005-10-10 2013-05-21 Boehringer Ingelheim Int 用於治療呼吸疾病之新穎藥物組合
US7423146B2 (en) 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
DE102005059602A1 (de) 2005-12-14 2007-06-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mikronisierung
WO2007075838A2 (en) * 2005-12-19 2007-07-05 Sicor Inc. Pure and stable tiotropium bromide
JP5086267B2 (ja) * 2005-12-19 2012-11-28 シコール インコーポレイティド 臭化チオトロピウムの新規な形態およびそれを製造する方法
WO2007077162A1 (en) * 2006-01-04 2007-07-12 Boehringer Ingelheim International Gmbh Use of tiotropium salts in the treatment of moderate persistent asthma
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
US20080051582A1 (en) 2006-07-10 2008-02-28 Sicor Inc. Process for the preparation of tiotropium bromide
WO2008017637A1 (de) 2006-08-07 2008-02-14 Boehringer Ingelheim International Gmbh Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
UY30550A1 (es) 2006-08-22 2008-03-31 Boehringer Ingelheim Int Nuevos beta-agonistas enantioméricamente puros, procedimientos para su preparacion y su uso como medicamentos
EP1923393A1 (en) * 2006-11-17 2008-05-21 Boehringer Ingelheim Pharma GmbH & Co. KG Crystalline form of tiotropium bromide and urea
EP1925295A1 (de) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stabile Pulverformulierung enthaltend ein Anticholinergikum
GB0716026D0 (en) * 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
MY153979A (en) 2007-10-19 2015-04-30 Boehringer Ingelheim Int Substituted piperidino-dihydrothienopyrimidine
EP2093219A1 (de) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
WO2010011813A1 (en) * 2008-07-23 2010-01-28 Alkermes, Inc. Complex of trospium and pharmaceutical compositions thereof
CN102256963B (zh) 2008-12-19 2014-06-11 贝林格尔.英格海姆国际有限公司 作为ccr2受体拮抗剂用于治疗炎症、哮喘和copd的环状嘧啶-4-甲酰胺
EP2201934A1 (en) 2008-12-23 2010-06-30 CHIESI FARMACEUTICI S.p.A. Tiotropium aerosol formulation products with improved chemical stability
WO2010101538A2 (en) 2009-03-06 2010-09-10 Bilgic Mahmut New crystal forms
AU2010280497B2 (en) 2009-08-07 2015-10-22 Generics [Uk] Limited Anhydrate of tiotropium bromide
WO2011015883A1 (en) 2009-08-07 2011-02-10 Generics [Uk] Limited Dichloromethane solvate of tiotropium bromide and its use
PT2513093E (pt) 2009-12-17 2014-10-22 Boehringer Ingelheim Int Novos antagonistas do receptor ccr2 e suas utilizações
US20130143905A1 (en) 2009-12-17 2013-06-06 Boehringer Ingelheim International Gmbh Novel antagonists for ccr2 and uses thereof
CN102822172A (zh) 2010-01-29 2012-12-12 贝林格尔.英格海姆国际有限公司 取代的二氮杂萘及其作为syk 激酶抑制剂的用途
EP2569298B1 (en) 2010-05-12 2015-11-25 Boehringer Ingelheim International GmbH Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
US8946218B2 (en) 2010-05-12 2015-02-03 Boehringer Ingelheim International Gmbh CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
JP5647339B2 (ja) 2010-05-17 2014-12-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｃｒ２アンタゴニスト及びこれらの使用
JP5636094B2 (ja) 2010-05-25 2014-12-03 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｃｒ２受容体アンタゴニスト
US8962656B2 (en) 2010-06-01 2015-02-24 Boehringer Ingelheim International Gmbh CCR2 antagonists
EP2668177B1 (en) 2011-01-28 2014-10-22 Boehringer Ingelheim International GmbH Substituted pyridinyl-pyrimidines and their use as medicaments
TR201102068A2 (tr) 2011-03-03 2012-09-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür içeren kristal maddeler
EP2721025B1 (en) 2011-06-16 2015-11-25 Boehringer Ingelheim International Gmbh New selective ccr2 antagonists
JP5786258B2 (ja) 2011-07-15 2015-09-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規かつ選択的なｃｃｒ２拮抗薬
MX336224B (es) 2011-07-26 2016-01-12 Boehringer Ingelheim Int Quinolinas sustituidas y su uso como medicamentos.
US20130059866A1 (en) 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
CZ304368B6 (cs) * 2011-11-28 2014-04-02 Zentiva, K.S. Směsný solvát tiotropium bromidu a způsob jeho přípravy
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
US9096579B2 (en) 2012-04-20 2015-08-04 Boehringer Ingelheim International Gmbh Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
SI2914593T1 (sl) 2012-11-05 2017-05-31 Zentiva, K.S. Stabilizacija tiotropijevih solvatov
EP2913332A1 (en) * 2014-02-27 2015-09-02 Euticals S.P.A. Crystalline form of tiotropium bromide with lactose
JP6535022B2 (ja) 2014-03-19 2019-06-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ヘテロアリールｓｙｋ阻害剤
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
RU2567539C1 (ru) * 2015-02-04 2015-11-10 Индивидуальный предприниматель Михайлов Олег Ростиславович КРИСТАЛЛИЧЕСКАЯ γ-МОДИФИКАЦИЯ (1α,2β,4β,5α,7β-7)-[(ГИДРОКСИДИ-2-ТИЕНИЛАЦЕТИЛ)ОКСИ]-9,9-ДИМЕТИЛ-3-ОКСА-9-АЗОНИАТРИЦИКЛО[3.3.1.02,4]НОНАН БРОМИДА МОНОГИДРАТА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕЁ ОСНОВЕ
WO2017138896A1 (en) 2016-02-11 2017-08-17 Sima Patent Ve Lisanslama Hizmetleri Ltd. Şti Crystalline form of tiotropium bromide anhydrate
EP3430011A4 (en) * 2016-11-04 2019-08-14 Sima Patent Ve Lisanslama Hizmetleri Ltd. STI NOVEL ACTIVE SUBSTANCE

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP0673240B1 (en) * 1992-12-09 1999-03-24 Boehringer Ingelheim Pharmaceuticals Inc. Stabilized medicinal aerosol solution formulations
DE19834506A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Transmucosales therapeutisches System zur Anwendung von Sildenafil
DK1102579T3 (da) * 1998-08-04 2003-07-14 Jago Res Ag Medicinske aerosolformuleringer

Also Published As

Publication number Publication date
JP2004526668A (ja) 2004-09-02
HK1060567A1 (en) 2004-08-13
EA200300457A1 (ru) 2003-10-30
SK4362003A3 (en) 2003-08-05
JP3764422B2 (ja) 2006-04-05
YU27303A (sh) 2006-05-25
HRP20030276A2 (en) 2005-02-28
RS50218B (sr) 2009-07-15
EP1326862A1 (de) 2003-07-16
CZ301841B6 (cs) 2010-07-07
KR20030042008A (ko) 2003-05-27
MY126931A (en) 2006-10-31
CA2425539C (en) 2007-04-03
NO328465B1 (no) 2010-02-22
AP1572A (en) 2006-02-13
OA12403A (en) 2006-04-18
CR6938A (es) 2004-10-28
AU1499602A (en) 2002-04-22
AR068527A2 (es) 2009-11-18
KR100823860B1 (ko) 2008-04-21
EG24142A (en) 2008-08-06
CN1221549C (zh) 2005-10-05
EE200300171A (et) 2003-06-16
ES2228965T3 (es) 2005-04-16
EE04567B1 (et) 2005-12-15
SI1326862T1 (sl) 2005-02-28
DE50103666D1 (de) 2004-10-21
MEP40008A (en) 2011-02-10
NO20031694L (no) 2003-04-11
PE20020422A1 (es) 2002-06-28
SK287009B6 (sk) 2009-09-07
SA01220412B1 (ar) 2006-11-05
HUP0301022A2 (hu) 2003-10-28
DK1326862T3 (da) 2004-11-22
PL366041A1 (en) 2005-01-24
MA25842A1 (fr) 2003-07-01
CN100519558C (zh) 2009-07-29
UY34901A (es) 2015-02-27
NZ525733A (en) 2005-01-28
AP2003002775A0 (en) 2003-03-31
ZA200302500B (en) 2004-04-22
IS6772A (is) 2003-04-09
HU226830B1 (en) 2009-11-30
ME00243B (me) 2011-05-10
BG107687A (bg) 2003-09-30
TW589313B (en) 2004-06-01
EP1468998A1 (de) 2004-10-20
CN1469877A (zh) 2004-01-21
TR200402579T4 (tr) 2004-12-21
UA74215C2 (uk) 2005-11-15
AU2002214996B2 (en) 2007-03-15
BR0114584A (pt) 2003-08-26
WO2002030928A1 (de) 2002-04-18
PL207870B1 (pl) 2011-02-28
EP1326862B1 (de) 2004-09-15
CA2425539A1 (en) 2003-04-11
HK1086557A1 (zh) 2006-09-22
NO20031694D0 (no) 2003-04-11
IL155335A (en) 2009-02-11
DZ3478A1 (fr) 2002-04-18
IL155335A0 (en) 2003-11-23
ATE276253T1 (de) 2004-10-15
CN1733761A (zh) 2006-02-15
AR034389A1 (es) 2004-02-25
GEP20063905B (en) 2006-08-25
EA004381B1 (ru) 2004-04-29
UY26962A1 (es) 2002-06-20
PT1326862E (pt) 2004-11-30
BG66161B1 (bg) 2011-09-30
HUP0301022A3 (en) 2005-12-28
MXPA03003221A (es) 2004-12-03
ECSP034540A (es) 2003-07-25
HRP20030276B1 (en) 2006-02-28

Similar Documents

Publication Publication Date Title
IS2339B (is) Kristallað tíótrópíumbrómíðmónóhýdrat, aðferð viðað framleiða það og notkun þess í framleiðslu á lyfi
NO2020007I1 (no) Sitagliptin, eventuelt i form av et farmasøytisk akseptabelt salt
NO2020019I1 (no) Maraviroc eventuelt i form av et farmasøytisk akseptabelt salt
IL159238A0 (en) Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
AU2002345016A1 (en) Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
AU2002214996A1 (en) Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
NO2010006I2 (no) Saksagliptin og farmasøytisk akseptable salter derav, inklusive saksagliptin hydroklorid
IL153273A0 (en) Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
AU2003222027A8 (en) Fast dissolving dosage forms having reduced friability
DK1532149T3 (da) 8-[3-amino-piperiden-1-yl]-xanthiner, fremstilling deraf og anvendelse deraf som lægemiddel
AU2001262318A1 (en) Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
AP2004003147A0 (en) Tropane derivatives useful in therapy
NO20032111D0 (no) Nye medikamentblandinger basert på tiotropium-salter og på salmeterol-salter
DK1513835T3 (da) Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf
DK1556382T3 (da) 3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf
PL359290A1 (en) Construction element and use of a support, and method for the production of an element for a facade
DK1333819T3 (da) Inhalativ oplösningsformulering med et tiotropiumsalt
IS2487B (is) Asýloxýpýrrólidín afleiður, framleiðsla og meðferðarnotkun þar á
DZ3364A1 (fr) Agent therapeutique cristallin
ITMI20001797A0 (it) Procedimento e dispositivo per la produzione, mediante adsorbimento, di azoto a purezza prefissata e costante.
ZA200308591B (en) Crystalline anticholinergic, method for its production, and use thereof in the production of a drug.
SI1294682T1 (en) Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
GB0208071D0 (en) Tropane derivatives useful in therapy